![]() |
Name |
3-[(7R,8S,8aS)-8-(2,4-dihydroxy-6-methylbenzoyl)oxy-7-hydroxy-7-methyl-6-oxo-8,8a-dihydro-1H-isochromen-3-yl]prop-2-enoic acid
|
Molecular Formula | C21H20O9 | |
IUPAC Name* |
3-[(7R,8S,8aS)-8-(2,4-dihydroxy-6-methylbenzoyl)oxy-7-hydroxy-7-methyl-6-oxo-8,8a-dihydro-1H-isochromen-3-yl]prop-2-enoic acid
|
|
SMILES |
CC1=CC(=CC(=C1C(=O)O[C@H]2[C@@H]3COC(=CC3=CC(=O)[C@]2(C)O)C=CC(=O)O)O)O
|
|
InChI |
InChI=1S/C21H20O9/c1-10-5-12(22)8-15(23)18(10)20(27)30-19-14-9-29-13(3-4-17(25)26)6-11(14)7-16(24)21(19,2)28/h3-8,14,19,22-23,28H,9H2,1-2H3,(H,25,26)/t14-,19+,21+/m1/s1
|
|
InChIKey |
ZDFHVFVPRFCIRZ-RFVSGWPVSA-N
|
|
Synonyms |
Pinazaphilone B
|
|
CAS | NA | |
PubChem CID | 139584952 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 416.4 | ALogp: | 1.5 |
HBD: | 4 | HBA: | 9 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 151.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 30 | QED Weighted: | 0.426 |
Caco-2 Permeability: | -5.744 | MDCK Permeability: | 0.00001940 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.954 |
Human Intestinal Absorption (HIA): | 0.249 | 20% Bioavailability (F20%): | 0.992 |
30% Bioavailability (F30%): | 0.969 |
Blood-Brain-Barrier Penetration (BBB): | 0.088 | Plasma Protein Binding (PPB): | 89.71% |
Volume Distribution (VD): | 0.397 | Fu: | 5.64% |
CYP1A2-inhibitor: | 0.444 | CYP1A2-substrate: | 0.097 |
CYP2C19-inhibitor: | 0.044 | CYP2C19-substrate: | 0.051 |
CYP2C9-inhibitor: | 0.342 | CYP2C9-substrate: | 0.196 |
CYP2D6-inhibitor: | 0.085 | CYP2D6-substrate: | 0.094 |
CYP3A4-inhibitor: | 0.28 | CYP3A4-substrate: | 0.248 |
Clearance (CL): | 5.194 | Half-life (T1/2): | 0.946 |
hERG Blockers: | 0.007 | Human Hepatotoxicity (H-HT): | 0.907 |
Drug-inuced Liver Injury (DILI): | 0.98 | AMES Toxicity: | 0.474 |
Rat Oral Acute Toxicity: | 0.909 | Maximum Recommended Daily Dose: | 0.973 |
Skin Sensitization: | 0.952 | Carcinogencity: | 0.536 |
Eye Corrosion: | 0.088 | Eye Irritation: | 0.826 |
Respiratory Toxicity: | 0.954 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003837 | ![]() |
0.636 | D0V9EN | ![]() |
0.261 | ||
ENC003304 | ![]() |
0.573 | D07MGA | ![]() |
0.257 | ||
ENC002606 | ![]() |
0.524 | D0KN2M | ![]() |
0.255 | ||
ENC002726 | ![]() |
0.510 | D08NQZ | ![]() |
0.241 | ||
ENC002211 | ![]() |
0.509 | D0Q0PR | ![]() |
0.235 | ||
ENC002132 | ![]() |
0.500 | D0YX4S | ![]() |
0.230 | ||
ENC002798 | ![]() |
0.477 | D04AIT | ![]() |
0.230 | ||
ENC002131 | ![]() |
0.455 | D0J2NK | ![]() |
0.228 | ||
ENC003448 | ![]() |
0.441 | D0R6RC | ![]() |
0.228 | ||
ENC005503 | ![]() |
0.440 | D0H0SJ | ![]() |
0.227 |